Temporal trends and drug exposures in pulmonary hypertension: An American experience (original) (raw)

Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases

rogerio souza

European Respiratory Journal, 2008

View PDFchevron_right

Anorexigens and Pulmonary Hypertension in the United States*

Alec Walker

Chest, 2000

View PDFchevron_right

Primary Pulmonary Hypertension Associated With the Use of Fenfluramine Derivatives

Muriel Fartoukh

CHEST Journal, 1998

View PDFchevron_right

Comparison of Survival in Patients With Pulmonary Hypertension Associated With Fenfluramine to Patients With Primary Pulmonary Hypertension

Alicia Shillington

View PDFchevron_right

Fenfluramine: riddle or Rosetta stone?

M. Obreztchikova

European Respiratory Journal, 2008

View PDFchevron_right

BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives

O. Sitbon

European Respiratory Journal, 2002

View PDFchevron_right

Longitudinal Effects of Fenfluramine—Phentermine Use

Dr. Richard M Fleming

Angiology, 2007

View PDFchevron_right

Drug-induced pulmonary arterial hypertension: a recent outbreak

David Montani

European respiratory review : an official journal of the European Respiratory Society, 2013

View PDFchevron_right

Dexfenfluramine protects against pulmonary hypertension in rats

Yoshihide Mitani

Journal of applied physiology (Bethesda, Md. : 1985), 2002

View PDFchevron_right

Chapter 8 Drug-and Toxin-Induced Pulmonary Arterial Hypertension

Laura Price

View PDFchevron_right

Use of dexfenfluramine, fenfluramine and phentermine and the risk of stroke

Hershel Jick

British Journal of Clinical Pharmacology, 2001

View PDFchevron_right

Chronic treatment with phentermine combined with fenfluramine lowers plasma serotonin

John Bantle

The American Journal of Cardiology, 2000

View PDFchevron_right

Drugs induced pulmonary arterial hypertension

David Montani

La Presse Médicale, 2013

View PDFchevron_right

The effects of chronic fenfluramine administration on behaviour and body weight

Max Taylor

Psychopharmacologia, 1973

View PDFchevron_right

A characterization of the acute cardiopulmonary toxicity of fenfluramine in the rat

R. Hunsinger

Pharmacological Research, 1990

View PDFchevron_right

Chronic Fenfluramine Administration Increases Plasma Serotonin (5-Hydroxytryptamine) to Nontoxic Levels

Dorota Zolkowska

Journal of Pharmacology and Experimental Therapeutics, 2007

View PDFchevron_right

Pulmonary Hypertension Associated with Use of Phentermine

Ji Yong Jang

Yonsei Medical Journal, 2010

View PDFchevron_right

d,l-fenfluramine challenge test: Experience in nonpatient sample

James Perel

Biological Psychiatry, 1996

View PDFchevron_right

Anorexigen-Associated Pulmonary Arterial Hypertension and the Serotonin Hypothesis: A Story Worth Telling

Sonja Bartolome

Advances in Pulmonary Hypertension

View PDFchevron_right

Drug-induced pulmonary arterial hypertension: a review

Ghulam Akbar

Heart Failure Reviews, 2017

View PDFchevron_right

Pulmonary Effects of Dexfenfluramine

Reyhan Egilmez

DergiPark (Istanbul University), 1998

View PDFchevron_right

Dexfenfluramine does not worsen but moderates progression of chronic hypoxia-induced pulmonary hypertension

Gilles Hanton

European Journal of Pharmacology, 2006

View PDFchevron_right

Fenfluramine: a plethora of mechanisms?

Jo Sourbron

Frontiers in Pharmacology, 2023

View PDFchevron_right

Serotonin Signaling in Pulmonary Hypertension

M. Caestecker

Circulation Research, 2006

View PDFchevron_right

Is DL-Fenfluramine a Potentially Helpful Drug Therapy in Overweight Adolescent Subjects?

Filippo Pedrinola

Obesity Research, 1994

View PDFchevron_right

Inverse Relationship Between Fenfluramine-Induced Prolactin Release and Blood Pressure in Humans

James Perel

Hypertension, 1998

View PDFchevron_right

The Acute Effects of Dexfenfluramine on Human and Porcine Pulmonary Vascular Tone and Resistance

George Cremona

Chest, 1999

View PDFchevron_right

Fenfluramine anorexia: A peripheral locus of action☆

John Rossi

Physiology & Behavior, 1983

View PDFchevron_right

Cardiovascular safety of low-dose fenfluramine in Dravet syndrome: a review of its benefit-risk profile in a new patient population

Bernard Paelinck

Current Medical Research and Opinion

View PDFchevron_right

Effect of fenfluramine on food intake, mood, and performance of humans living in a residential laboratory

Richard Foltin

Physiology & Behavior, 1996

View PDFchevron_right

Study of human urinary metabolism of fenfluramine using gas chromatography—mass spectrometry

Bruce Campbell

Journal of Chromatography B: Biomedical Sciences and Applications, 1991

View PDFchevron_right

Fenfluramine and norfenfluramine levels in brain microdialysate, brain tissue and plasma of rats administered doses of d-fenfluramine known to deplete 5-hydroxytryptamine levels in brain

Peter Clausing

The Journal of pharmacology and experimental therapeutics, 1998

View PDFchevron_right

Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension

I. Morecroft

Cardiovascular Research, 2013

View PDFchevron_right

Prevalence and Determinants of Valvulopathy in Patients Treated With Dexfenfluramine

Carlos Roldán

Circulation, 1999

View PDFchevron_right